CANCEROUS DISEASE MODIFYING ANTIBODIES

摘要

The present invention relates to a method for producing patient cancerous disease modifying antibodies using a novel paradigm of screening. By segregating the anti-cancer antibodies using cancer cell cytotoxicity as an end point, the process makes possible the production of anti-cancer antibodi es for therapeutic and diagnostic purposes. The antibodies can be used in aid o f staging and diagnosis of a cancer, and can be used to treat primary tumors a nd tumor metastases. The anti-cancer antibodies can be conjugated to toxins, enzymes, radioactive compounds, and hematogenous cells.